Aneurysmal subarachnoid haemorrhage: Effect of CRHR1 genotype on mental health-related quality of life.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
20 01 2020
Historique:
received: 22 07 2019
accepted: 31 12 2019
entrez: 22 1 2020
pubmed: 22 1 2020
medline: 26 11 2020
Statut: epublish

Résumé

Quality of life (QoL) disturbances are common after aneurysmal subarachnoid hemorrhage (aSAH) both in physical and mental health domains and their causes are not clearly understood. Corticotropin-releasing hormone receptor 1 (CRHR1) is involved in stress reactivity and development of mental health disturbances after negative life-events. We performed a retrospective cohort study of long-term QoL outcomes among 125 surgically treated aSAH patients (2001-2013). QoL was assessed with Short Form Health Survey (SF-36) and compared to an age and gender matched general population. Genotyping of CRHR1 single nucleotide polymorphisms was performed (Rs7209436, Rs110402, Rs242924) and their effect on QoL scores was explored. aSAH patients experienced a reduced quality of life in all domains. CRHR1 minor genotype was associated with higher SF-36 mental health (OR = 1.31-1.6, p < 0.05), role-emotional (OR = 1.57, p = 0.04) and vitality scores (OR = 1.31-1.38, p < 0.05). Association of all studied SNP's with vitality and Rs242924 with mental health scores remained statistically significant after Bonferroni correction. Mental quality of life scores were associated with physical state of patients, antidepressant history and CRHR1 genotype. Predisposition to mental health disturbances after stressful life-events might be associated with reduced mental QoL after aSAH and selected patients could be provided advanced counselling in the recovery phase.

Identifiants

pubmed: 31959877
doi: 10.1038/s41598-020-57527-4
pii: 10.1038/s41598-020-57527-4
pmc: PMC6971041
doi:

Substances chimiques

Receptors, Corticotropin-Releasing Hormone 0
CRF receptor type 1 5CLY6W2H1M

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

724

Références

Rinkel, G. J. E. & Algra, A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol. 10, 349–356 (2011).
pubmed: 21435599 doi: 10.1016/S1474-4422(11)70017-5
Etminan, N. et al. Worldwide Incidence of Aneurysmal Subarachnoid Hemorrhage According to Region, Time Period, Blood Pressure, and Smoking Prevalence in the Population. JAMA Neurol. 76, 588–597 (2019).
pubmed: 30659573 doi: 10.1001/jamaneurol.2019.0006
Korja, M., Lehto, H., Juvela, S. & Kaprio, J. Incidence of subarachnoid hemorrhage is decreasing together with decreasing smoking rates. Neurology 87, 1118–1123 (2016).
pubmed: 27521438 pmcid: 5027805 doi: 10.1212/WNL.0000000000003091
Nieuwkamp, D. J. et al. Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis. Lancet Neurol. 8, 635–642 (2009).
pubmed: 19501022 doi: 10.1016/S1474-4422(09)70126-7
Noble, A. J. & Schenk, T. Which variables help explain the poor health-related quality of life after subarachnoid hemorrhage? A meta-analysis. Neurosurgery 66, 772–783 (2010).
pubmed: 20190663 doi: 10.1227/01.NEU.0000367548.63164.B2
Kreiter, K. T. et al. Depressed mood and quality of life after subarachnoid hemorrhage. J. Neurol. Sci. 335, 64–71 (2013).
pubmed: 24064259 doi: 10.1016/j.jns.2013.08.024
Von-Vogelsang, A. C., Forsberg, C., Svensson, M. & Wengström, Y. Patients Experience High Levels of Anxiety 2 Years Following Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 83, 1090–1097 (2015).
pubmed: 25535065 doi: 10.1016/j.wneu.2014.12.027
Passier, P. E. C. A., Visser-Meily, J. M. A., Rinkel, G. J. E., Lindeman, E. & Post, M. W. M. Life Satisfaction and Return to Work After Aneurysmal Subarachnoid Hemorrhage. J. Stroke Cerebrovasc. Dis. 20, 324–329 (2011).
pubmed: 20656515 doi: 10.1016/j.jstrokecerebrovasdis.2010.02.001
Gerritsen, L. et al. HPA Axis Genes, and Their Interaction with Childhood Maltreatment, are Related to Cortisol Levels and Stress-Related Phenotypes. Neuropsychopharmacology 42, 2446–2455 (2017).
pubmed: 28589964 pmcid: 5645736 doi: 10.1038/npp.2017.118
Gold, P. W. The organization of the stress system and its dysregulation in depressive illness. Mol. Psychiatry 20, 32–47 (2015).
pubmed: 25486982 doi: 10.1038/mp.2014.163
Wasserman, D., Wasserman, J. & Sokolowski, M. Genetics of HPA-axis, depression and suicidality. Eur. Psychiatry 25, 278–280 (2010).
pubmed: 20444578 doi: 10.1016/j.eurpsy.2009.12.016
Naughton, M., Dinan, T. G. & Scott, L. V. Corticotropin-releasing hormone and the hypothalamic–pituitary–adrenal axis in psychiatric disease. Handb. Clin. Neurol. 124, 69–91 (2014).
pubmed: 25248580 doi: 10.1016/B978-0-444-59602-4.00005-8
Liu, Z. et al. Association study of corticotropin-releasing hormone receptor1 gene polymorphisms and antidepressant response in major depressive disorders. Neurosci. Lett. 414, 155–158 (2007).
pubmed: 17258395 doi: 10.1016/j.neulet.2006.12.013
Ishitobi, Y. et al. Association of CRHR1 and CRHR2 with major depressive disorder and panic disorder in a Japanese population. Am. J. Med. Genet. Part B Neuropsychiatr. Genet. 159B, 429–436 (2012).
doi: 10.1002/ajmg.b.32046
White, S. et al. Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults. J. Anxiety Disord. 27, 678–83 (2013).
pubmed: 24077033 pmcid: 4182958 doi: 10.1016/j.janxdis.2013.08.003
Liu, Z. et al. Negative life events and corticotropin-releasing-hormone receptor1 gene in recurrent major depressive disorder. Sci. Rep. 3, 1–5 (2013).
Tyrka, A. R., Price, L. H., Gelernter, J., Anderson, G. M. & Carpenter, L. L. Interaction of childhood maltreatment with corticotropin-releasing hormone receptor gene: effect on HPA axis reactivity. Biol. Psychiatry 66, 681–685 (2009).
pubmed: 19596121 pmcid: 2881567 doi: 10.1016/j.biopsych.2009.05.012
Mahon, P. B. Genetic Association of FKBP5 and CRHR1 with Cortisol Response to Acute Psychosocial Stress in Healthy Adults. Psychopharmacol. 227, 231–241 (2013).
doi: 10.1007/s00213-012-2956-x
Sumner, J. A., McLaughlin, K. A., Walsh, K., Sheridan, M. A. & Koenen, K. C. CRHR1 genotype and history of maltreatment predict cortisol reactivity to stress in adolescents. Psychoneuroendocrinology 43, 71–80 (2014).
pubmed: 24703172 pmcid: 3986273 doi: 10.1016/j.psyneuen.2014.02.002
Kreitschmann-Andermahr, I. et al. Quality of life and psychiatric sequelae following aneurysmal subarachnoid haemorrhage: Does neuroendocrine dysfunction play a role? Clin. Endocrinol. (Oxf). 66, 833–837 (2007).
pubmed: 17408419 doi: 10.1111/j.1365-2265.2007.02821.x
Vetkas, A., Lepik, T., Eilat, T., Rätsep, T. & Asser, T. Emotional health and quality of life after aneurysmal subarachnoid hemorrhage. Acta Neurochir. (Wien). 155, 1107–1114 (2013).
pubmed: 23532345 doi: 10.1007/s00701-013-1683-3
Alfieri, A. et al. Psychosocial and neurocognitive performance after spontaneous nonaneurysmal subarachnoid hemorrhage related to the APOE- ε 4 genotype: a prospective 5-year follow-up study. J. Neurosurg. 109, 1019–1026 (2008).
pubmed: 19035714 doi: 10.3171/JNS.2008.109.12.1019
Hunt, W. E. & Hess, R. M. Surgical Risk as Related to Time of Intervention in the Repair of Intracranial Aneurysms. J. Neurosurg. 28, 14–20 (1968).
pubmed: 5635959 doi: 10.3171/jns.1968.28.1.0014
Van-Swieten, J. C., Koudstaal, P. J., Visser, M. C., Schouten, H. J. & van Gijn, J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19, 604–7 (1988).
pubmed: 3363593 doi: 10.1161/01.STR.19.5.604
McHorney, C. A., Ware, J. E. & Raczek, A. E. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med. Care 31, 247–63 (1993).
pubmed: 8450681 doi: 10.1097/00005650-199303000-00006
McHorney, C. A., Ware, J. E., Lu, J. F. & Sherbourne, C. D. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med. Care 32, 40–66 (1994).
pubmed: 8277801 doi: 10.1097/00005650-199401000-00004
Miller, S. A., Dykes, D. D. & Polesky, H. F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 16, 1215 (1988).
pubmed: 3344216 pmcid: 334765 doi: 10.1093/nar/16.3.1215
Najera-Zuloaga, J., Lee, D.-J. & Arostegui, I. Comparison of beta-binomial regression model approaches to analyze health-related quality of life data. Stat. Methods Med. Res. 27, 2989–3009 (2018).
pubmed: 29298606 doi: 10.1177/0962280217690413
Arostegui, I., Núñez-Antón, V. & Quintana, J. M. Analysis of the short form-36 (SF-36): the beta-binomial distribution approach. Stat. Med. 26, 1318–1342 (2007).
pubmed: 16795124 doi: 10.1002/sim.2612
Almborg, A. & Berg, S. Quality of life among Swedish patients after stroke: Psychometric evaluation of SF-36. J. Rehabil. Med. 41, 48–53 (2009).
pubmed: 19197569 doi: 10.2340/16501977-0287
Brown, N. et al. Quality of life four years after acute myocardial infarction: short form 36 scores compared with a normal population. Heart 81, 352–8 (1999).
pubmed: 10092560 pmcid: 1728997 doi: 10.1136/hrt.81.4.352
Cumming, T. B., Packer, M., Kramer, S. F. & English, C. The prevalence of fatigue after stroke: A systematic review and meta-analysis. Int. J. Stroke 11, 968–977 (2016).
pubmed: 27703065 doi: 10.1177/1747493016669861
Bradley, R. G. et al. Influence of child abuse on adult depression: moderation by the corticotropin-releasing hormone receptor gene. Arch. Gen. Psychiatry 65, 190 (2008).
pubmed: 18250257 pmcid: 2443704 doi: 10.1001/archgenpsychiatry.2007.26
Davydow, D. S. et al. A pilot investigation of the association of genetic polymorphisms regulating corticotrophin-releasing hormone with posttraumatic stress and depressive symptoms in medical-surgical intensive care unit survivors. J. Crit. Care 29, 101–106 (2014).
pubmed: 24075295 doi: 10.1016/j.jcrc.2013.08.016
Visser-Meily, J. M. A. et al. Post-Traumatic stress disorder in patients 3 years after aneurysmal subarachnoid haemorrhage. Cerebrovasc. Dis. 36, 126–130 (2013).
pubmed: 24029667 doi: 10.1159/000353642
Hedlund, M., Zetterling, M., Ronne-Engström, E., Carlsson, M. & Ekselius, L. Depression and post-traumatic stress disorder after aneurysmal subarachnoid haemorrhage in relation to lifetime psychiatric morbidity. Br. J. Neurosurg. 25, 693–700 (2011).
pubmed: 21591856 pmcid: 3233275 doi: 10.3109/02688697.2011.578769
Passier, P. E. C. A., Visser-Meily, J. M. A., Rinkel, G. J. E., Lindeman, E. & Post, M. W. M. Determinants of health-related quality of life after aneurysmal subarachnoid hemorrhage: A systematic review. Qual. Life Res. 22, 1027–1043 (2013).
pubmed: 22956388 doi: 10.1007/s11136-012-0236-1
Meyer, B. et al. Health-Related Quality of Life in Patients with Subarachnoid Haemorrhage. Cerebrovasc. Dis. 30, 423–431 (2010).
pubmed: 20720412 doi: 10.1159/000317078
Persson, H. C., Carlsson, L. & Sunnerhagen, K. S. Life situation 5 years after subarachnoid haemorrhage. Acta Neurol. Scand. 137, 99–104 (2018).
pubmed: 28869279 doi: 10.1111/ane.12815
He, S. & Mack, W. J. Health-Related Quality of Life After Aneurysmal Subarachnoid Hemorrhage: Interplay Between Physical, Cognitive, and Emotional Factors. World Neurosurg. 81, 37–39 (2014).
pubmed: 23333474 doi: 10.1016/j.wneu.2013.01.066
Rivero-Arias, O., Gray, A. & Wolstenholme, J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff. Resour. Alloc. 8, 6 (2010).
pubmed: 20423472 pmcid: 2874525 doi: 10.1186/1478-7547-8-6
Crago, E. A. et al. Impaired Work Productivity After Aneurysmal Subarachnoid Hemorrhage. J. Neurosci. Nurs. 48, 260–268 (2016).
pubmed: 27579960 pmcid: 5032650 doi: 10.1097/JNN.0000000000000209
Al-Yassin, A., Ouyang, B. & Temes, R. Depression and Anxiety Following Aneurysmal Subarachnoid Hemorrhage Are Associated With Higher Six-Month Unemployment Rates. J. Neuropsychiatry Clin. Neurosci. 29, 67–69 (2017).
pubmed: 27417068 doi: 10.1176/appi.neuropsych.15070171
Sonesson, B., Kronvall, E., Säveland, H., Brandt, L. & Nilsson, O. G. Long-term reintegration and quality of life in patients with subarachnoid hemorrhage and a good neurological outcome: findings after more than 20 years. J. Neurosurg. 128, 785–792 (2018).
pubmed: 28452618 doi: 10.3171/2016.11.JNS16805
Richardson, J., Iezzi, A., Khan, M. A., Chen, G. & Maxwell, A. Measuring the Sensitivity and Construct Validity of 6 Utility Instruments in 7 Disease Areas. Med. Decis. Mak. 36, 147–159 (2016).
doi: 10.1177/0272989X15613522
Linde, L., Sørensen, J., Ostergaard, M., Hørslev-Petersen, K. & Hetland, M. L. Health-related quality of life: validity, reliability, and responsiveness of SF-36, 15D, EQ-5D [corrected] RAQoL, and HAQ in patients with rheumatoid arthritis. J. Rheumatol. 35, 1528–37 (2008).
pubmed: 18484697
McDonough, C. M. et al. Comparison of EQ-5D, HUI, and SF-36-derived societal health state values among spine patient outcomes research trial (SPORT) participants. Qual. Life Res. 14, 1321–32 (2005).
pubmed: 16047507 pmcid: 2782497 doi: 10.1007/s11136-004-5743-2
Rautalin, M. et al. Health-related quality of life in different states of breast cancer – comparing different instruments. Acta Oncol. (Madr). 57, 622–628 (2018).
doi: 10.1080/0284186X.2017.1400683

Auteurs

Artur Vetkas (A)

Tartu University Hospital, Tartu, Estonia. Artur.Vetkas@kliinikum.ee.

Ele Prans (E)

Tartu University, Tartu, Estonia.

Sulev Kõks (S)

Centre for Molecular Medicine and Innovative Therapeutics, Murdoch University, Perth, WA, Australia.
The Perron Institute for Neurological and Translational Science, Perth, WA, Australia.

Tõnu Rätsep (T)

Tartu University Hospital, Tartu, Estonia.

Toomas Asser (T)

Tartu University Hospital, Tartu, Estonia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH